These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10406639)

  • 1. Solid phase synthesis and biological activities of [Arg8]-vasopressin methylenedithioether.
    Ueki M; Ikeo T; Iwadate M; Asakura T; Williamson MP; Slaninová J
    Bioorg Med Chem Lett; 1999 Jul; 9(13):1767-72. PubMed ID: 10406639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analogs of arginine vasopressin modified in position 3 with (R)-alpha-hydroxymethylphenylalanine.
    Lempicka E; Slaninova J; Olma A; Lammek B
    J Pept Res; 1999 May; 53(5):554-9. PubMed ID: 10424351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of N-terminal part modification of arginine vasopressin analogues with 2-aminoindane-2-carboxylic acid: a highly potent V2 agonist.
    Kowalczyk W; Sobolewski D; Prahl A; Derdowska I; Borovicková L; Slaninová J; Lammek B
    J Med Chem; 2007 Jun; 50(12):2926-9. PubMed ID: 17500550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginine vasopressin and its analogues--the influence of position 2 modification with 3,3-diphenylalanine enantiomers. Highly potent V2 agonists.
    Kwiatkowska A; Sobolewski D; Prahl A; Borovicková L; Slaninová J; Lammek B
    Eur J Med Chem; 2009 Jul; 44(7):2862-67. PubMed ID: 19418631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological activities of arginine-vasopressin analogues with 4-hydroxyproline in position 7.
    Buku A; Schwartz IL; Yamin N; Wyssbrod HR; Gazis D
    J Med Chem; 1987 Aug; 30(8):1509-12. PubMed ID: 3612693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and renal effects of Ala-Gly-[Arg8]-vasopressin.
    Chan YL; Smith CW
    Biochem Biophys Res Commun; 1980 Sep; 96(2):626-31. PubMed ID: 7426004
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and some pharmacological properties of deamino(4-threonine,8-D-arginine)vasopressin and deamino(8-D-arginine)vasopressin, highly potent and specific antidiuretic peptides, and (8-D-arginine)vasopressin and deamino-arginine-vasopressin.
    Manning M; Balaspiri L; Moehring J; Haldar J; Sawyer WH
    J Med Chem; 1976 Jun; 19(6):842-5. PubMed ID: 950656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidiuretic and pressor activities of vasopressin analogs with L-alaninamide and D-alaninamide substitutions at position 9.
    Buku A; Gazis D; Schwartz IL
    Int J Pept Protein Res; 1984 May; 23(5):551-7. PubMed ID: 6547408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [1-(L-2-hydroxy-3-mercaptopropanoic acid)] analogues of arginine-vasopressin, [8-D-arginine]vasopressin, and [4-valine,8-D-arginine]vasopressin.
    Lowbridge J; Manning M; Haldar J; Sawyer W
    J Med Chem; 1977 Sep; 20(9):1173-6. PubMed ID: 926117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological activities of some new arginine vasopressin analogues containing unusual amino acids.
    Varga C; Somlai C; Baláspiri L; László FA
    Acta Physiol Hung; 1993; 81(2):183-92. PubMed ID: 8197874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-Acetyl-[2-(O-methyl)tyrosine]arginine-vasopressin, an interesting antagonist of the vasopressor response to vasopressin.
    Jones DA; Sawyer WH
    J Med Chem; 1980 Jun; 23(6):696-8. PubMed ID: 7392038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of 8-D-arginine vasopressin analogues, modified in position 1 as antagonists of the vasopressor response to the parent hormone.
    Lammek B; Derdowska I; Melin P
    Pol J Pharmacol Pharm; 1988; 40(4):423-8. PubMed ID: 3222181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-Proline and 4-hydroxyproline analogs of arginine vasopressin: role of the proline substitution in the two beta-turns of vasopressin.
    Buku A; Yamin N; Gazis D
    Experientia; 1987 Dec; 43(11-12):1218-9. PubMed ID: 3691742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analogs of arginine vasopressin modified in the N-terminal part of the molecule with a conformationally constrained cis-peptide bond motif.
    Sobolewski D; Prahl A; Derdowska I; Slaninová J; Kaczmarek K; Zabrocki J; Lammek B
    J Pept Sci; 2007 Feb; 13(2):128-32. PubMed ID: 17146804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
    Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
    J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly potent 1-aminocyclohexane-1-carboxylic acid substituted V2 agonists of arginine vasopressin.
    Kowalczyk W; Prahl A; Derdowska I; Dawidowska O; Slaninová J; Lammek B
    J Med Chem; 2004 Nov; 47(24):6020-4. PubMed ID: 15537356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical syntheses and biological studies on dimeric chimeras of oxytocin and the V(2)-antagonist, d(CH(2))(5)[D-Ile(2), Ile(4)]arginine vasopressin.
    Chen L; Golser R; Machová A; Slaninová J; Barany G
    J Med Chem; 1999 Dec; 42(24):5002-9. PubMed ID: 10585209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasopressin analogs that antagonize antidiuretic responses by rats to the antidiuretic hormone.
    Sawyer WH; Pang PK; Seto J; McEnroe M; Lammek B; Manning M
    Science; 1981 Apr; 212(4490):49-51. PubMed ID: 7209515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggressive role of vasopressin in development of different gastric lesions in rats.
    László F; Karácsony G; Pávó I; Varga C; Rojik I; László FA
    Eur J Pharmacol; 1994 Jun; 258(1-2):15-22. PubMed ID: 7925594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surprising pharmacological activity of analogues designed by substitution of position 3 in arginine vasopressin (AVP) and 8-D-arginine vasopressin with L-2-napthylalanine.
    Lammek B; Konieczna E; Trzeciak HI; Kozłowski A; Szymkowiak J; Stojko R; Kupryszewski G
    J Pharm Pharmacol; 1996 Mar; 48(3):316-9. PubMed ID: 8737061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.